- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Upcoming Dividends
Hong Kong Pharmaceuticals & Biotech Upcoming Dividends
Results
8
Companies which have announced upcoming dividend payments.
8 companies
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$5.5b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine products to wholesalers and individuals.
3613
HK$6.53
7D
-2.4%
1Y
-22.0%
Tong Ren Tang Technologies
Market Cap: HK$4.2b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.29
7D
-8.1%
1Y
-30.9%
Pak Fah Yeow International
Market Cap: HK$735.5m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.36
7D
-2.9%
1Y
-4.5%
Consun Pharmaceutical Group
Market Cap: HK$11.2b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$13.32
7D
-3.4%
1Y
19.6%
Jilin Province Huinan Changlong Bio-pharmacy
Market Cap: HK$1.5b
Manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People’s Republic of China.
8049
HK$2.68
7D
4.7%
1Y
13.6%
Sino Biopharmaceutical
Market Cap: HK$81.7b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$4.58
7D
-2.6%
1Y
-8.2%
CSPC Pharmaceutical Group
Market Cap: HK$78.8b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$6.89
7D
-4.8%
1Y
-9.6%
China Resources Pharmaceutical Group
Market Cap: HK$28.3b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.50
7D
-7.0%
1Y
-12.3%